Skip to main content
News Tag: news
NRG Oncology Adds New Theranostics Subcommittee to Organization, New Leadership Members for CCDR & Early Phase Trial Oversight Committees
Read More
NRG Oncology Study Suggests the Addition of SBRT to Systemic Therapy Improves Outcomes for Select Patients with Locally Advanced Hepatocellular Carcinoma
Read More
Legacy Tribute: In Honor of Felix Feng, MD
Read More
Dr. Lisa Kachnic Named NRG Oncology NCORP Co-Principal Investigator
Read More
NRG Oncology Study Reaffirms Standard of Cetuximab and Radiation for Patients with Locoregionally Advanced Head and Neck Cancer and a Contraindication to Cisplatin
Read More
Dr. Joan Walker Pivots from NRG NCORP Leadership Role to Focus on Mentorship
Read More
Advocate Angle: “Life’s a journey – travel well”
Read More
Advocate Angle: Improving the Cancer Clinical Trial Matching Ecosystem
Read More
FORTE Study Updates: November 2024
Read More
NRG-GU011 (“NRG PROMETHEAN”): stereotactic radiotherapy with or without relugolix for PET-recurrent oligometastatic prostate cancer
Read More